Literature DB >> 14720519

EGF receptor transactivation by urokinase receptor stimulus through a mechanism involving Src and matrix metalloproteinases.

Javier Guerrero1, Juan Francisco Santibañez, Alfonso González, Jorge Martínez.   

Abstract

Urokinase-type plasminogen activator receptor (uPAR) and epidermal growth factor receptor (EGFR) are ubiquitous receptors involved in the control of a variety of cellular processes frequently found altered in cancer cells. The EGFR has been recently described to play a transduction role of uPAR stimuli, mediating uPA-induced proliferation in highly malignant cells that overexpress uPAR. In the present work, we found for the first time that uPAR stimulation with the amino-terminal fragment (ATF) of urokinase devoid of proteolytic activity transactivates the EGFR in mammary MCF-7 cells through a mechanism involving Src and a metalloproteinase, as indicated by its sensitivity to selected inhibitors. In these cells, which express low levels of uPAR and malignancy, both ATF and EGF stimuli induced an interaction of the EGFR with uPAR and ERK activation. However, EGFR activation by uPAR stimuli mediated cellular invasion rather than proliferation, while EGFR activation by EGF led to a proliferative response. These results revealed a complex modulation of EGFR function toward different cellular responses according to the status of uPAR activity. On the other hand, we also found that MMP-mediated activation of EGFR can occur in an autocrine manner in cells which secrete uPA. All this reveals novel regulatory systems operating through autocrine loops involving uPAR stimuli, Src, MMP and EGFR activation which could mediate fine control of physiological processes as well as contribute to the expression of proliferative and invasive phenotypes of cancerous cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14720519     DOI: 10.1016/j.yexcr.2003.08.011

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  24 in total

1.  Functional convergence of signalling by GPI-anchored and anchorless forms of a salamander protein implicated in limb regeneration.

Authors:  Robert A Blassberg; Acely Garza-Garcia; Azara Janmohamed; Phillip B Gates; Jeremy P Brockes
Journal:  J Cell Sci       Date:  2010-11-30       Impact factor: 5.285

2.  Regulation of proteinases during mouse peri-implantation development: urokinase-type plasminogen activator expression and cross talk with matrix metalloproteinase 9.

Authors:  M G Martínez-Hernández; L A Baiza-Gutman; A Castillo-Trápala; D Randall Armant
Journal:  Reproduction       Date:  2010-11-12       Impact factor: 3.906

3.  Mechanisms of endothelin-1-induced MAP kinase activation in adrenal glomerulosa cells.

Authors:  Bukhtiar H Shah; Albert J Baukal; Hung-Dar Chen; Ali B Shah; Kevin J Catt
Journal:  J Steroid Biochem Mol Biol       Date:  2006-12       Impact factor: 4.292

4.  Number and brightness image analysis reveals ATF-induced dimerization kinetics of uPAR in the cell membrane.

Authors:  Christian Hellriegel; Valeria R Caiolfa; Valeria Corti; Nicolai Sidenius; Moreno Zamai
Journal:  FASEB J       Date:  2011-05-20       Impact factor: 5.191

5.  Blood-brain barrier breakdown and repair by Src after thrombin-induced injury.

Authors:  Da-Zhi Liu; Bradley P Ander; Huichun Xu; Yan Shen; Pali Kaur; Wenbin Deng; Frank R Sharp
Journal:  Ann Neurol       Date:  2010-04       Impact factor: 10.422

6.  Src family kinase inhibitor PP2 efficiently inhibits cervical cancer cell proliferation through down-regulating phospho-Src-Y416 and phospho-EGFR-Y1173.

Authors:  Lu Kong; Zhihong Deng; Haiying Shen; Yuxiang Zhang
Journal:  Mol Cell Biochem       Date:  2010-11-04       Impact factor: 3.396

7.  Vasopressin up-regulates the expression of growth-related immediate-early genes via two distinct EGF receptor transactivation pathways.

Authors:  Lida Q Fuentes; Carlos E Reyes; José M Sarmiento; Carolina I Villanueva; Carlos D Figueroa; Javier Navarro; Carlos B González
Journal:  Cell Signal       Date:  2008-05-25       Impact factor: 4.315

8.  EGF regulates plasminogen activator inhibitor-1 (PAI-1) by a pathway involving c-Src, PKCdelta, and sphingosine kinase 1 in glioblastoma cells.

Authors:  Barbara S Paugh; Steven W Paugh; Lauren Bryan; Dmitri Kapitonov; Katarzyna M Wilczynska; Sunita M Gopalan; Hanna Rokita; Sheldon Milstien; Sarah Spiegel; Tomasz Kordula
Journal:  FASEB J       Date:  2007-09-12       Impact factor: 5.191

9.  Hepatocyte growth factor (HGF) modulates GABAergic inhibition and seizure susceptibility.

Authors:  Mihyun H Bae; Gregory B Bissonette; Wendy M Mars; George K Michalopoulos; Cristian L Achim; Didier A Depireux; Elizabeth M Powell
Journal:  Exp Neurol       Date:  2009-10-22       Impact factor: 5.330

Review 10.  Urokinase and its receptors in chronic kidney disease.

Authors:  Guoqiang Zhang; Allison A Eddy
Journal:  Front Biosci       Date:  2008-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.